Skip to content
Home › 13F recaps › Q3 2026 › RVMD

Which funds bought or sold RVMD in Q3 2026?

Revolution Medicines Inc. 7 funds bought, 8 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$807M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold RVMD, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (7)

FundChangeEst. $Now
Fidelity
Asset manager
Added+26.2%+$656M$3.2B
Capital World
Asset manager
Added+36.2%+$298M$1.1B
Jane Street
Quant & multi-strategy
Added+5411.1%+$152M$155M
CPP Investments
Sovereign & pension
New+$82M$82M
Legal & General
Asset manager
Added+61.3%+$48M$126M
CalPERS
Sovereign & pension
Added+57.5%+$41M$113M
Duquesne
Family office & foundation
Added+9.2%+$8M$90M

Sold (8)

FundChangeEst. $Now
Schwab
Index giant
Trimmed-48.2%−$189M$204M
UBS
Bank & broker
Trimmed-15.9%−$177M$941M
Two Sigma
Quant & multi-strategy
Trimmed-87.6%−$133M$19M
T. Rowe Price
Asset manager
Sold out−$109M—
Adage
Hedge fund
Trimmed-87.4%−$107M$15M
General Atlantic
Venture capital
Sold out−$67M—
a16z
Venture capital
Trimmed-15%−$28M$161M
Fisher Investments
Asset manager
Trimmed-35.2%−$15M$28M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.